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Abstract
Background: While most of the global burden from chronic diseases, and especially vascular
diseases, is now borne by low and middle-income countries, few large-scale epidemiological studies
of chronic diseases in such countries have been performed.
Methods: From 1998–2004, 52 584 men and 106 962 women aged ≥35 years were visited in their
homes in Mexico City. Self reported diagnoses of chronic diseases and major disease risk factors
were ascertained and physical measurements taken. Age- and sex-specific prevalences and means
were analysed.
Results: After about age 50 years, diabetes was extremely common – for example, 23.8% of men
and 26.9% of women aged 65–74 reported a diagnosis. By comparison, ischaemic heart disease was
reported by 4.8% of men and 3.0% of women aged 65–74, a history of stroke by 2.8% and 2.3%,
respectively, and a history of cancer by 1.3% and 2.1%. Cancer history was generally more common
among women than men – the excess being largest in middle-age, due to breast and cervical cancer.
At older ages, the gap narrowed because of an increasing prevalence of prostate cancer. 51% of
men and 25% of women aged 35–54 smoked cigarettes, while 29% of men and 41% of women aged
35–54 were obese (i.e. BMI ≥30 kg/m2). The prevalence of treated hypertension or measured blood
pressure ≥140/90 mmHg increased about 50% more steeply with age among women than men, to
66% of women and 58% of men aged 65–74. Physical inactivity was highly prevalent but daily alcohol
drinking was relatively uncommon.
Conclusion: Diabetes, obesity and tobacco smoking are highly prevalent among adults living in
Mexico City. Long-term follow-up of this and other cohorts will establish the relevance of such
factors to the major causes of death and disability in Mexico.
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Background
Most of the total global burden from chronic diseases in
middle age, and especially from vascular diseases, is now
borne by low- and middle-income countries [1]. This is
due partly to reductions in the risk of dying young (espe-
cially from infectious diseases and nutritional deficien-
cies) in many of these countries, and probably also to
increases in lifestyle characteristics (e.g. tobacco, obesity)
known to cause chronic diseases in high-income coun-
tries. However, to date, there have been few large epidemi-
ological studies of chronic diseases, or of their causes, in
lower income countries. There is consequently a need for
a greater understanding of both the distribution of
chronic diseases in lower income countries, and the distri-
bution of possible lifestyle risk factors, so that appropriate
health care and preventive strategies can be put in place.
Mexico is an example of a large middle-income country in
the midst of such a transition, with diabetes, ischaemic
heart disease (IHD), stroke and alcoholic liver disease all
now leading causes of death in middle-age [2]. In this
paper, the age- and sex-specific distributions of a range of
chronic diseases and potentially modifiable risk factors is
assessed in a reasonably representative sample of over 150
000 adults living in Mexico City (one of the world's most
populous cities). The findings are directly relevant to cur-
rent health care provision and disease prevention in Mex-
ico City, and they may be indirectly relevant to other parts
of Latin America and elsewhere.
Methods
The rationale and methods for the Mexico City Prospec-
tive Study have been described previously [3] and are
briefly summarised below.
Recruitment of study population
The study was initiated in the mid-1990s to assess associ-
ations of established risk factors, and of possible new risk
factors, with the main causes of death in Mexico City.
Between April 1998 and September 2004, study teams,
each consisting of two or three specially trained nurses,
surveyed 159 546 adults aged at least 35 years (52 584
men and 106 962 women) from two urban districts of
Mexico City (at an average rate of ~2000 per month). The
two districts were selected because they contained a
diverse, but settled, mix of long-term residents and rela-
tively recent migrants from throughout Mexico, with peo-
ple from a wide range of different socio-demographic
backgrounds [3]. One district (Coyoacán) has a full spec-
trum of incomes apart from the extremely high and
extremely low; the other (Iztapalapa) has mostly middle
and lower incomes, but again without the extremes. Dur-
ing the home visit a baseline questionnaire was com-
pleted by means of an interviewer-administered electronic
handheld data recorder, physical measurements (includ-
ing blood pressure and anthropometric measurements)
were recorded, and a blood sample was taken [3].
Baseline questionnaire
Participants were asked whether they had ever been diag-
nosed with any of the following: diabetes (type unspeci-
fied), heart attack, angina, hypertension, stroke, chronic
obstructive pulmonary disease (COPD), chronic kidney
disease (CKD), liver cirrhosis, peptic ulcer, cancer at sev-
eral specific sites (lung, prostate, cervix, breast, oesopha-
gus/stomach/intestine, mouth/nose/throat), or any other
cancer. Ischaemic heart disease (IHD) was defined as a
heart attack or angina.
Participants were asked a range of questions about
tobacco, including detailed questions regarding past
smoking habits and the number of cigarettes smoked each
day. They were also asked about their frequency and
intensity of recreational physical activity, their current and
previous alcohol drinking habits, and their diet.
Physical measurements
Height, weight, waist circumference and hip circumfer-
ence were measured, and body mass index (BMI) was cal-
culated as weight in kilograms divided by the square of
height in metres (kg/m2). "Obesity" was defined as a BMI
of 30 kg/m2 or more. Seated blood pressure was measured
on each of three occasions, with the average of the three
measurements being used in analyses. "High blood pres-
sure" was defined as treated hypertension, measured
systolic blood pressure (SBP) ≥140 mmHg, or measured
diastolic blood pressure (DBP) ≥90 mmHg. All physical
measurements were entered into handheld data recorders,
which automatically queried moderately extreme meas-
urements and prevented highly implausible measure-
ments from being recorded. Further statistical plausibility
checks were performed centrally and, if necessary, the val-
ues were rechecked by field workers.
Ethical approval
The study was approved by the Central Oxford Research
Ethics Committee and by the National Council on Science
and Technology (CONACYT: Consejo Nacional de Cien-
cia y Tecnología).
Statistical analyses
The primary analyses of disease and risk factor prevalence
were stratified by age and sex. In the tables, participants
are shown in five 10-year age groups from 35–44 years to
75–84 years at baseline, excluding the small numbers of
participants aged ≥85 years. In the figures, however, infor-
mation from all men and women is shown, men being
separated into five, and women into ten, equally sized age
groups (so that each of these groups contains information
on just over 10 000 people), with estimates of disease andB
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Table 1: Age-specific prevalence (%) of some major diseases, by sex (51 768 men and 105 313 women aged 35–84 years)
No. (%) with disease
Cancer
Age at
resurvey
Number
recruited
Diabetes IHD Stroke Cervix Breast Prostate Other Any COPD CKD Cirrhosis Peptic
ulcer
Men 35–44 16777 804
(4.8%)
72
(0.4%)
61
(0.4%)
--3
(0.0%)
32
(0.2%)
34
(0.2%)
12
(0.1%)
86
(0.5%)
18
(0.1%)
252
(1.5%)
45–54 13776 1811
(13.1%)
171
(1.2%)
106
(0.8%)
--8
(0.1%)
45
(0.3%)
53
(0.4%)
20
(0.1%)
87
(0.6%)
25
(0.2%)
260
(1.9%)
55–64 10259 2064
(20.1%)
279
(2.7%)
167
(1.6%)
-- 2 5
(0.2%)
58
(0.6%)
81
(0.8%)
52
(0.5%)
122
(1.2%)
48
(0.5%)
255
(2.5%)
65–74 7300 1736
(23.8%)
352
(4.8%)
202
(2.8%)
-- 4 9
(0.7%)
49
(0.7%)
96
(1.3%)
88
(1.2%)
81
(1.1%)
39
(0.5%)
199
(2.7%)
75–84 3656 712
(19.5%)
198
(5.4%)
127
(3.5%)
-- 4 9
(1.3%)
45
(1.2%)
91
(2.5%)
65
(1.8%)
38
(1.0%)
12
(0.3%)
132
(3.6%)
Women 35–44 37591 1474
(3.9%)
146
(0.4%)
166
(0.4%)
170
(0.5%)
57
(0.2%)
-1 0 3
(0.3%)
326
(0.9%)
19
(0.1%)
246
(0.7%)
8
(0.0%)
463
(1.2%)
45–54 29413 3586
(12.2%)
228
(0.8%)
247
(0.8%)
194
(0.7%)
141
(0.5%)
-1 5 1
(0.5%)
475
(1.6%)
34
(0.1%)
257
(0.9%)
25
(0.1%)
471
(1.6%)
55–64 19303 4418
(22.9%)
321
(1.7%)
270
(1.4%)
152
(0.8%)
124
(0.6%)
-1 2 6
(0.7%)
396
(2.1%)
51
(0.3%)
232
(1.2%)
30
(0.2%)
340
(1.8%)
65–74 13025 3505
(26.9%)
392
(3.0%)
299
(2.3%)
116
(0.9%)
70
(0.5%)
-9 3
(0.7%)
273
(2.1%)
62
(0.5%)
138
(1.1%)
16
(0.1%)
297
(2.3%)
75–84 5981 1368
(22.9%)
243
(4.1%)
180
(3.0%)
43
(0.7%)
48
(0.8%)
-5 1
(0.9%)
140
(2.3%)
53
(0.9%)
57
(1.0%)
13
(0.2%)
132
(2.2%)
IHD = ischaemic heart disease, COPD = chronic obstructive pulmonary disease, CKD = chronic kidney disease
The standard errors for each of the estimated prevalences above are small: for cancers (< 0.3% [≤ 0.1% excluding age range 75–84 years]); for COPD (≤ 0.2%); for CKD (< 0.2%); for cirrhosis (< 0.1%) and 
for peptic ulcer (≤ 0.3%). For diabetes, IHD and stroke, 95% confidence intervals around prevalence estimates are shown in Figure 1.BMC Public Health 2009, 9:9 http://www.biomedcentral.com/1471-2458/9/9
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risk factor prevalence (together with their 95% confidence
intervals) being plotted against the mean age of each
group. Throughout the Results section, emphasis is placed
on reporting estimates rather than testing hypotheses
since with a study of this size, even small and clinically
unimportant differences can be highly statistically signifi-
cant. However, where particular significance tests have
(for clarity) been reported, the p-values are 2-sided. Anal-
yses were performed using SAS version 8.2 [4] and figures
were produced using R version 2.2.1 [5].
Results
Prevalence of chronic diseases by age and sex
Table 1 shows the self-reported prevalences of several
chronic diseases by age and sex, and Figure 1 displays the
prevalences for diabetes, IHD and stroke (together with
their associated 95% confidence intervals).
Diabetes
23.8% of men and 26.9% of women aged 65 to 74
reported having been diagnosed with diabetes. The preva-
lence was somewhat lower at younger ages, but even at
35–44 years it was 4.8% in men and 3.9% in women
(with standard errors < 0.2%). In early middle age there
was a minor excess of males reporting diabetes, whereas at
older ages there was a modest excess of females; the prev-
alence therefore tended to increase slightly more rapidly
with baseline age in females than males (Figure 1).
IHD and stroke
In each sex, the prevalences of reported IHD and stroke
increased continuously with baseline age. At 65–74 years,
4.8% of men and 3.0% of women reported a history of
IHD, and 2.8% and 2.3%, respectively, reported a history
of stroke (all standard errors < 0.3%). The prevalence of
IHD was higher in men than women at all ages, the rela-
tive difference being greatest at around 70 years of age, but
the absolute difference continuing to widen with age even
beyond that (Figure 1). In contrast, the prevalence of prior
stroke was similar in men and women up to about age 55,
after which there was a slight excess among men.
Cancer
At 65–74 years, just 1.3% of men and 2.1% of women
reported a history of cancer. At younger ages, a history of
cancer was relatively much more common in women than
Sex-specific prevalence of diabetes, IHD and stroke at different ages Figure 1
Sex-specific prevalence of diabetes, IHD and stroke at different ages. IHD = ischaemic heart disease. Unadjusted 
prevalences with 95% confidence intervals are shown. Each point involves ~10 000 people.
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men, due to breast cancer and – especially – to cervical
cancer. At older ages the gap narrowed because of an
increasing prevalence of prostate cancer. Compared with
these three sex-specific cancers, a history of cancer at other
specific sites was, at all ages and in each sex, much less
common.
Other diseases
In each sex the prevalence of COPD at least doubled with
each decade of age until old age. The prevalence was
always greater in men than women, and the gap widened
with age, so by age 65–74, men (1.2%) were more than
twice as likely as women (0.5%) to report having the dis-
ease (p < 0.00001). In each sex, the prevalence of CKD
increased with age up to about 60 years, beyond which it
levelled off or possibly decreased. At age 55–84, about 1%
of either sex had CKD, but at younger ages, when the prev-
alences were lower, there was a minor excess of women
with this diagnosis. Cirrhosis was generally more preva-
lent at older than at younger ages, and also among men
than among women. For example, about 0.5% of men,
compared with about 0.2% of women (p < 0.00001),
aged 55–64 reported this condition. A history of peptic
ulceration was nearly twice as prevalent at ages 65–74
(men: 2.7%; women 2.3%) as among people three dec-
ades younger (men: 1.5%; women 1.2%); both p <
0.00001.
Prevalence of major disease risk factors, by age and sex
Table 2 shows the prevalences of some behaviours and
physical characteristics known to be major disease risk
factors in many countries, by age and sex.
Smoking
At all ages, only about 20% of men had never smoked reg-
ularly (Figure 2). However, while at age 35–44 there were
about twice as many current smokers as ex-smokers, at age
75–84 there were twice as many ex-smokers as current
Table 2: Age-specific prevalences and means of selected risk factors, by sex (51 768 men and 105 313 women aged 35–84 years)
Tobacco smoking
Age at
resurvey
Number
recruited
Never Former Current Mean (SD)
BMI, kg/m2
Mean (SD)
waist:hip ratio
Mean (SD)
SBP/DBP,
mmHg
Daily
drinking
Men 35–44 16777 3539
(21.1%)
4313
(25.7%)
8922
(53.2%)
28.0
(4.5)
0.93
(0.06)
123/83
(12/9)
291
(1.7%)
45–54 13776 2718
(19.7%)
4497
(32.6%)
6559
(47.6%)
28.2
(4.4)
0.95
(0.06)
127/85
(15/10)
333
(2.4%)
55–64 10259 2034
(19.8%)
4272
(41.7%)
3949
(38.5%)
28.1
(4.2)
0.97
(0.07)
132/86
(17/10)
339
(3.3%)
65–74 7300 1445
(19.8%)
3685
(50.5%)
2169
(29.7%)
27.6
(4.2)
0.97
(0.07)
136/86
(18/11)
293
(4.0%)
75–84 3656 845
(23.1%)
2044
(55.9%)
766
(21.0%)
26.7
(3.9)
0.97
(0.07)
136/84
(18/11)
172
(4.7%)
Women 35–44 37591 20855
(55.5%)
6370
(17.0%)
10355
(27.6%)
29.1
(5.2)
0.86
(0.06)
119/79
(13/9)
60
(0.2%)
45–54 29413 17780
(60.5%)
5210
(17.7%)
6410
(21.8%)
30.1
(5.4)
0.87
(0.07)
126/83
(16/10)
82
(0.3%)
55–64 19303 13307
(68.9%)
3449
(17.9%)
2544
(13.2%)
30.2
(5.3)
0.89
(0.07)
132/85
(17/10)
75
(0.4%)
65–74 13025 9484
(72.9%)
2348
(18.0%)
1185
(9.1%)
29.5
(5.2)
0.91
(0.07)
137/85
(18/11)
78
(0.6%)
75–84 5981 4504
(75.3%)
1141
(19.1%)
334
(5.6%)
28.0
(5.0)
0.92
(0.08)
139/85
(19/11)
58
(1.0%)
Prevalences and means unadjusted. No. with missing values: smoking 48, BMI 1781, blood pressure 314, drinking 62. The median BMI levels for men 
and women were: 27.6, 27.9, 27.8, 27.3, 26.6; and 28.4, 29.5, 29.7, 29.0, 27.7 respectivelyBMC Public Health 2009, 9:9 http://www.biomedcentral.com/1471-2458/9/9
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smokers. In contrast, most women had never smoked reg-
ularly (56% at age 35–44 increasing to 75% at age 75–
84); younger women were much more likely to be current
smokers, however, than older women (28% and 6% at
ages 35–44 and 75–84 respectively; p < 0.00001). In old
age, men were three to four times as likely as women to
smoke, but in early middle age they were only twice as
likely. Among current smokers, the average number of cig-
arettes smoked per day was higher among men (about 6–
8 cigarettes per day) than women (about 4–6 cigarettes
per day; see Additional file 1), and tended to be higher
among older people.
BMI and the waist to hip ratio
The mean BMI in this population was 27.9 kg/m2 in men
and 29.5 kg/m2 in women [3]. In addition to women hav-
ing higher mean BMI than men, BMI levels were also
more widely dispersed in women than men (SD generally
1 kg/m2 larger: Table 2); consequently the prevalence of
obesity (BMI ≥ 30 kg/m2) was substantially higher in
women than men (41% vs 27% respectively; p <
0.00001). In men, obesity was most prevalent between
the ages of 40 and 60 (~30%), and least prevalent in old
age (though still ~20%); see Figure 3. At all ages, the prev-
alence was substantially higher in women than men,
reaching a maximum of 47% among women between the
ages of 50 and 60. The mean waist-to-hip ratio was 0.95
and 0.88 in men and women respectively (p < 0.00001).
It increased with age (at least up to age 55–64 in men) and
was higher for men than women at all ages.
Blood pressure
The mean systolic/diastolic blood pressure (SBP/DBP)
was 13/3 mmHg higher at ages 65–74 than at ages 35–44
(i.e., about 30 years younger) for men, and 18/6 mmHg
higher for women (the SE's of these differences were ≤ 0.2
mmHg for both SBP and DBP in both sexes). The preva-
lence of high blood pressure (treated hypertension, SBP
≥140 mmHg or DBP ≥90 mmHg) increased sharply
between the ages 35–44 and 75–84, from 26% to 59% in
men and, even more sharply from 19% to 70% in women
(Figure 3). The difference between men and women in the
rate at which SBP increased with age was not much
explained by differences in BMI (the F statistic for the
interaction term between age and gender was 859 before,
and 776 after, adjustment for BMI). Moreover, at least up
Sex-specific prevalence of tobacco smoking (current, former and never) at different ages Figure 2
Sex-specific prevalence of tobacco smoking (current, former and never) at different ages. Unadjusted prevalences 
with 95% confidence intervals are shown. Each point involves ~10 000 people.
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to about age 65, the mean SBP in women was similar to
or lower than that in men despite the mean BMI being 1–
2 kg/m2 higher in women.
Physical inactivity, alcohol and diet
Recreational physical inactivity was highly prevalent at all
ages; overall, 71% of men and 82% of women reported
that they did not do any such activity (Figure 3). In both
sexes, the prevalence of daily drinking increased steadily
with age, but daily drinking was rare even among elderly
women (about 1% at 75–84) and not common even
among elderly men (about 5% at 75–84). Overall, average
fruit and vegetable consumption was marginally higher
among women than men (mean [SD] number of days that
men and women, on average, ate fruit and vegetables: 4.2
[1.9] vs 4.6 [1.7] days per week; p < 0.00001), and, in both
men and women, consumption tended to be a little
higher among older people (data not shown). Consump-
tion of fried foods was more common among men than
women (mean [SD] number of days that men and
women, on average, consumed fried foods: 2.6 [1.9] vs 2.2
[1.7] days per week; p < 0.00001), and was more common
among younger people (data not shown).
Discussion
This study of over 150 000 adults shows the extent and
distribution of reported chronic diseases and major dis-
ease risk factors prevalent among men and women in
Mexico City at the start of the 21st century. Due to the
study's size and use of streamlined procedures (including
electronically-entered interviewer-administered question-
naires) [3], it has been possible to assess reliably how
these reported prevalences vary with age and sex. While
the results from this study may not be directly relevant to
diseases with a short life expectancy (such as lung cancer:
see below), the results are especially relevant to the provi-
sion of public health services in Mexico City for chronic
conditions such as diabetes, particularly since the study
population is reasonably representative of the general
population of middle-aged and elderly adults living in
this city. Moreover, it is possible that the true disease prev-
alences are even higher because of the "healthy partici-
Sex-specific prevalence of obesity, high blood pressure and physical inactivity at different ages Figure 3
Sex-specific prevalence of obesity, high blood pressure and physical inactivity at different ages. Unadjusted prev-
alences with 95% confidence intervals are shown. Each point involves ~10 000 people. Obesity = BMI ≥ 30 kg/m2. High blood 
pressure = treated hypertension, SBP ≥ 140 mmHg or DBP ≥ 90 mmHg. Physical inactivity = no regular recreational physical 
activity.
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pant" effect (i.e., the tendency for participants in
epidemiological studies to be healthier than the overall
population).
In particular, the overall prevalence of diabetes in Mexico
City is high, with about one in four adults aged around 70
reporting this condition. This is somewhat higher than
has been reported in other surveys in Mexico [6-8],
although this may reflect differences in assessment of dia-
betes (the present study used self-reported medical diag-
nosis, others have used detailed questionnaires and
capillary glucose measurements) or differences in geo-
graphical setting (the present study is wholly urban, oth-
ers have been nationally representative). The higher
prevalence among women than men above about age 55
years contrasts with the higher prevalence among men
than women at lower ages. This cannot be accounted for
by any tendency for one sex to under- (or over-) report
diabetes diagnoses, unless that tendency differed qualita-
tively with age. Nor can it be accounted for by mean BMI
level, which was consistently 1–2 kg/m2 higher in women
than men at all ages
Diabetes is an important cause of vascular disease, and by
about age 70, around 1 in 20 men and 1 in 30 women had
a history of IHD (and just over half as many of the men
and three-quarters as many of the women had a history of
stroke). The higher prevalences among men were despite
a lower mean BMI and (at this age) a lower prevalence of
diabetes, although the prevalence of smoking – another
important cause of vascular disease in many populations
– was much higher among men then women. However,
the extent to which smoking causes vascular disease in
Mexico has not yet been established; the same is true for
obesity, diabetes, blood pressure, lipoproteins and possi-
ble novel risk factors for vascular disease.
Whereas by about age 70 diabetes was highly prevalent,
and a history of vascular disease moderately prevalent,
just 1 in 75 men and 1 in 50 women had a history of can-
cer. However, many cancers kill quite quickly and so
would not contribute much to prevalence. For example, in
2005 lung cancer accounted for 1 in 30 male deaths and 1
in 70 female deaths at ages 60–69 in Mexico [9] but it con-
tributed only negligibly to cancer prevalence because of its
poor prognosis. The main contributors to cancer preva-
lence in the present study were three sex-specific cancers
that generally have a better prognosis: cancers of the pros-
tate, breast and cervix. Cervical cancer was by far the most
prevalent cancer before age 65 in either sex, and cancer at
this site is also an unusually common cause of death
among middle-aged women in Mexico. For example, in
2005 it was attributed as the cause of death in 24 out of
every 100 000 women aged 50–59 years, compared with
5 per 100 000 in the US and 4 per 100 000 in Canada [9].
It is not known whether Mexico's high cervical cancer
mortality in middle age is related in some way to its high
prevalence of, for example, diabetes.
By around age 70, about 1 in 80 men and 1 in 200 women
in this study reported a history of COPD. These preva-
lences are much lower than the prevalence of significant
airway obstruction in a survey of 1000 adults in Mexico
City [10], which, although very much smaller than the
present study, employed spirometric assessment rather
than self-report. There may well be substantial misdiagno-
sis, including underdiagnosis, of COPD in Mexico as in
other Latin American countries [10]. Similarly, there may
well be underdiagnosis of CKD [11], so the prevalences in
the present report might be substantial underestimates.
Furthermore, the possibility of some under-reporting of
cirrhosis (and, indeed, of alcohol intake) cannot be
excluded: despite the low prevalence in this study (about
1 in 200 men at age 70 and 1 in 800 women), recent
national mortality data indicate that some 10% of all
male, and 5% of all female, deaths in Mexico at ages 60–
69 are attributed to this disease [9]. Studies in other coun-
tries indicate that both cirrhosis and CKD can be caused
by obesity and by diabetes, but the quantitative relevance
of these risk factors to liver or kidney disease in Mexico
has not yet been established.
This report demonstrates a high prevalence of tobacco
smoking in Mexican men, particularly at younger ages.
Half of Mexican men in early middle-age (35–44), and
one quarter of Mexican women, smoke tobacco. The
observation that the proportion of male current smokers
fell with increasing age while the proportion of male ex-
smokers rose (Figure 2) is likely to reflect the increased
likelihood of quitting with time due, in part, to the accu-
mulation of ill health with increasing age (for instance,
the prevalence of IHD was consistently higher among ex-
smokers than current smokers for men and women at all
ages; Additional file 2).
Conclusion
Diabetes, obesity and tobacco smoking are highly preva-
lent among adults living in Mexico City. While the impact
of these risk factors on mortality and morbidity in this
cohort cannot yet be assessed, continued follow-up will
allow detailed estimation of their age- and sex-specific rel-
evance to major causes of death and disability [3]. The
unusually high levels of obesity and diabetes in this study
may mean that the results will be relevant not only to
Mexico, but also to the many countries in which the prev-
alences of obesity and diabetes are currently increasing.
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